NeuroSense Therapeutics Ltd. (NRSN)

NeuroSense Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.17	3.38	2.64	3.54	11.06
Short-Term Investments	-	-	-	3.55	-
Cash & Short-Term Investments	0.17	3.38	2.64	7.09	11.06
Cash Growth	-95.09%	27.96%	-62.76%	-35.91%	1482.69%
Other Receivables	0.57	0.99	0.24	0.26	0.31
Total Trade Receivables	0.57	0.99	0.24	0.26	0.31
Other Current Assets	0.05	0.04	0.04	0.04	0.04
Total Current Assets	0.78	4.4	2.92	7.38	11.41
Net Property, Plant & Equipment	0.23	0.15	0.25	0.31	0.02
Other Long-Term Assets	0.02	0.02	0.02	0.02	-
Total Assets	1.03	4.58	3.19	7.71	11.43
Accounts Payable	0.8	1.16	1.46	0.5	0.04
Accrued Expenses	-	-	-	1.23	0.56
Other Current Liabilities	1.72	0.83	2	-	-
Total Current Liabilities	2.52	1.99	3.46	1.73	0.6
Long-Term Leases	0.07	-	-	-	-
Total Long-Term Liabilities	0.07	-	-	-	-
Total Liabilities	2.59	1.99	4.94	2.09	2.43
Additional Paid-in Capital	46.23	39.24	24.36	26.41	17.45
Retained Earnings	-47.79	-36.66	-26.12	-20.79	-8.45
Shareholders' Equity	-1.56	2.58	-1.76	5.62	9.01
Total Liabilities & Equity	1.03	4.58	3.19	7.71	11.43
Total Debt	0.07	0	0	0	0
Net Cash (Debt)	0.09	3.38	2.64	7.09	11.06
Net Cash Growth	-97.22%	27.96%	-62.76%	-35.91%	1482.69%
Net Cash Per Share	0.00	0.18	0.19	0.62	1.77
Book Value	-1.56	2.58	-1.76	5.62	9.01
Book Value Per Share	-0.06	0.14	-0.13	0.49	1.44
Tangible Book Value	-1.56	2.58	-1.76	5.62	9.01
Tangible Book Value Per Share	-0.06	0.14	-0.13	0.49	1.44

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error